It is hence possible that downregulation or loss of CUL5 in ccRCC may further fuel neo-angiogenesis, which plays a central role in ccRCC driven by VHL loss, thus promoting tumor progression. The gene discussed is CUL5; the disease is nonpapillary renal cell carcinoma.